These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 17597105

  • 1. Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: Implication for cancer intervention.
    Yan R, Zu X, Ma J, Liu Z, Adeyanju M, Cao D.
    Int J Cancer; 2007 Nov 15; 121(10):2301-6. PubMed ID: 17597105
    [Abstract] [Full Text] [Related]

  • 2. Aldo-keto reductase 1B10 protects human colon cells from DNA damage induced by electrophilic carbonyl compounds.
    Zu X, Yan R, Pan J, Zhong L, Cao Y, Ma J, Cai C, Huang D, Liu J, Chung FL, Liao DF, Cao D.
    Mol Carcinog; 2017 Jan 15; 56(1):118-129. PubMed ID: 26969882
    [Abstract] [Full Text] [Related]

  • 3. Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls.
    Wang C, Yan R, Luo D, Watabe K, Liao DF, Cao D.
    J Biol Chem; 2009 Sep 25; 284(39):26742-8. PubMed ID: 19643728
    [Abstract] [Full Text] [Related]

  • 4. Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells.
    Ma J, Yan R, Zu X, Cheng JM, Rao K, Liao DF, Cao D.
    J Biol Chem; 2008 Feb 08; 283(6):3418-3423. PubMed ID: 18056116
    [Abstract] [Full Text] [Related]

  • 5. Inhibiting proliferation and migration of lung cancer using small interfering RNA targeting on Aldo-keto reductase family 1 member B10.
    Zhou Z, Zhao Y, Gu L, Niu X, Lu S.
    Mol Med Rep; 2018 Feb 08; 17(2):2153-2160. PubMed ID: 29207124
    [Abstract] [Full Text] [Related]

  • 6. AKR1B10, a transcriptional target of p53, is downregulated in colorectal cancers associated with poor prognosis.
    Ohashi T, Idogawa M, Sasaki Y, Suzuki H, Tokino T.
    Mol Cancer Res; 2013 Dec 08; 11(12):1554-63. PubMed ID: 24140838
    [Abstract] [Full Text] [Related]

  • 7. Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma.
    Chung YT, Matkowskyj KA, Li H, Bai H, Zhang W, Tsao MS, Liao J, Yang GY.
    Mod Pathol; 2012 May 08; 25(5):758-66. PubMed ID: 22222635
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Knockdown or inhibition of aldo-keto reductase 1B10 inhibits pancreatic carcinoma growth via modulating Kras-E-cadherin pathway.
    Zhang W, Li H, Yang Y, Liao J, Yang GY.
    Cancer Lett; 2014 Dec 28; 355(2):273-80. PubMed ID: 25304374
    [Abstract] [Full Text] [Related]

  • 10. Impact of aldo-keto reductase family 1 member B10 on the risk of hepatitis C virus-related hepatocellular carcinoma.
    Sato S, Genda T, Ichida T, Murata A, Tsuzura H, Narita Y, Kanemitsu Y, Ishikawa S, Kikuchi T, Mori M, Hirano K, Iijima K, Wada R, Nagahara A, Watanabe S.
    J Gastroenterol Hepatol; 2016 Jul 28; 31(7):1315-22. PubMed ID: 26758591
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sulindac inhibits pancreatic carcinogenesis in LSL-KrasG12D-LSL-Trp53R172H-Pdx-1-Cre mice via suppressing aldo-keto reductase family 1B10 (AKR1B10).
    Li H, Yang AL, Chung YT, Zhang W, Liao J, Yang GY.
    Carcinogenesis; 2013 Sep 28; 34(9):2090-8. PubMed ID: 23689354
    [Abstract] [Full Text] [Related]

  • 13. Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC.
    Torres-Mena JE, Salazar-Villegas KN, Sánchez-Rodríguez R, López-Gabiño B, Del Pozo-Yauner L, Arellanes-Robledo J, Villa-Treviño S, Gutiérrez-Nava MA, Pérez-Carreón JI.
    Dig Dis Sci; 2018 Apr 28; 63(4):934-944. PubMed ID: 29383608
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Effects of AKR1B10 gene silence on the growth and gene expression of HCC cell line MHCC97H].
    Wei W, Liang HJ, Cui JF, Guo K, Kang XN, Cao J, Su JJ, Li Y, Liu YK.
    Zhonghua Gan Zang Bing Za Zhi; 2010 Sep 28; 18(9):666-71. PubMed ID: 20943077
    [Abstract] [Full Text] [Related]

  • 16. Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer.
    Taskoparan B, Seza EG, Demirkol S, Tuncer S, Stefek M, Gure AO, Banerjee S.
    Cell Oncol (Dordr); 2017 Dec 28; 40(6):563-578. PubMed ID: 28929377
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinoma.
    Sato S, Genda T, Hirano K, Tsuzura H, Narita Y, Kanemitsu Y, Kikuchi T, Iijima K, Wada R, Ichida T.
    Liver Int; 2012 Oct 28; 32(9):1382-90. PubMed ID: 22681639
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.